Filters
Tests names and labs | Conditions | Genes, analytes, and microbes | Methods |
---|---|---|---|
Molecular Otolaryngology and Renal Research Laboratories University of Iowa Hospital and Clinics United States | 287 | 218 |
|
Molecular Vision Laboratory United States | 1358 | 1028 |
|
PCDH15 - NGS including CNV analysis Centogene AG - the Rare Disease Company Germany | 3 | 1 |
|
Invitae Comprehensive Deafness Panel Labcorp Genetics (formerly Invitae) LabCorp United States | 405 | 219 |
|
Labcorp Genetics (formerly Invitae) LabCorp United States | 32 | 17 |
|
Intergen Intergen Genetics and Rare Diseases Diagnosis Center Turkey | 1 | 1 |
|
Intergen Intergen Genetics and Rare Diseases Diagnosis Center Turkey | 1 | 1 |
|
Invitae Inherited Retinal Disorders Panel Labcorp Genetics (formerly Invitae) LabCorp United States | 486 | 293 |
|
Invitae Broad Carrier Screen without X-linked Disorders Labcorp Genetics (formerly Invitae) LabCorp United States | 195 | 98 |
|
Labcorp Genetics (formerly Invitae) LabCorp United States | 224 | 112 |
|
Invitae Comprehensive Carrier Screen Labcorp Genetics (formerly Invitae) LabCorp United States | 886 | 547 |
|
Myriad Genetics, Inc. United States | 2 | 1 |
|
Hereditary Hearing Loss and Deafness Panel PreventionGenetics, part of Exact Sciences United States | 361 | 224 |
|
Molecular Vision Laboratory United States | 342 | 268 |
|
Quantitative Genomic Medicine Laboratories, SL Spain | 327 | 300 |
|
PCDH15 Deletion/Duplication Analysis Baylor Genetics United States | 3 | 1 |
|
PCDH15 Comprehensive - Sequence & Deletion/Duplication Analysis Baylor Genetics United States | 3 | 1 |
|
Usher Syndrome Type 1 and Deafness, Autosomal Recessive 23 (DFNB23) via the PCDH15 Gene PreventionGenetics, part of Exact Sciences United States | 3 | 1 |
|
Comprehensive Hearing Loss + mtDNA MNG Laboratories (Medical Neurogenetics, LLC.) United States | 218 | 300 |
|
Dyslipidemia and early atherosclerosis panel. 84-gene NGS panel. Genologica Medica Spain | 133 | 84 |
|
IMPORTANT NOTE: NIH does not independently verify information submitted to the GTR; it relies on submitters to provide information that is accurate and not misleading. NIH makes no endorsements of tests or laboratories listed in the GTR. GTR is not a substitute for medical advice. Patients and consumers with specific questions about a genetic test should contact a health care provider or a genetics professional.